Literature DB >> 2900022

Inhibition by heparin of the oxidation of lysine in collagen by lysyl oxidase.

P Gavriel1, H M Kagan.   

Abstract

The generation of covalent cross-linkages in collagen is initiated by the deamination by lysyl oxidase of specific lysine residues in this connective tissue protein. Since lysyl oxidase activity is influenced by ionic ligands bound to its protein substrates, the effect of heparin, an anionic glycosaminoglycan known to bind to collagen, was explored by using collagen and elastin substrates and highly purified lysyl oxidase. Concentrations of heparin up to 1 mg mL-1 had little effect on the enzymatic rate of oxidation if it was added prior to the addition of enzyme to a preformed fibrillar collagen substrate or to an insoluble elastin substrate. However, collagen oxidation was inhibited by 85% if this glycosaminoglycan was present at 0.4 mg mL-1 during collagen fibril formation before addition of the enzyme. Similarly, the rate and extent of collagen fibrillogenesis in the absence of lysyl oxidase were each markedly inhibited in the presence of 0.4 mg mL-1 heparin. Heparin also inhibited the extent of tight binding of lysyl oxidase to preformed fibrils by about 40% under conditions where enzyme activity against preformed fibrils was hardly affected. These results suggest that heparin may modulate the oxidation and thus the insolubilization of extracellular collagen fibers, possibly under conditions where elastin fiber synthesis is not affected, and that the tight binding of lysyl oxidase to collagen is not completely related to the expression of enzyme activity toward this substrate. These results also have mechanistic implications for the retarding effect of heparin on postoperative wound healing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900022     DOI: 10.1021/bi00408a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion.

Authors:  Kristin L Reigle; Gloria Di Lullo; Kevin R Turner; Jerold A Last; Inna Chervoneva; David E Birk; James L Funderburgh; Elizabeth Elrod; Markus W Germann; Charles Surber; Ralph D Sanderson; James D San Antonio
Journal:  J Cell Biochem       Date:  2008-08-01       Impact factor: 4.429

2.  Purification, properties and influence of dietary copper on accumulation and functional activity of lysyl oxidase in rat skin.

Authors:  N Romero-Chapman; J Lee; D Tinker; J Y Uriu-Hare; C L Keen; R R Rucker
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

3.  Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells.

Authors:  A D Snow; R P Bolender; T N Wight; A W Clowes
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

4.  Smooth muscle cell expression of extracellular matrix genes after arterial injury.

Authors:  S T Nikkari; H T Järveläinen; T N Wight; M Ferguson; A W Clowes
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

5.  Warfarin Use Is Associated with Increased Mortality at One Year in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Syeda Fatima Naqvi; Amir Humza Sohail; Dhairya A Lakhani; James Maurer; Sarah Sofka; Yousaf B Hadi
Journal:  Pulm Med       Date:  2021-11-25

6.  Anti-aging effect and gene expression profiling of dung beetle glycosaminoglycan in aged rats.

Authors:  Mi Young Ahn; Ban Ji Kim; Ha Jeong Kim; Jae Sam Hwang; Yi-Sook Jung; Kun-Koo Park
Journal:  Biomater Res       Date:  2017-04-21

7.  Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale.

Authors:  Rob Janssen; Emiel Fm Wouters; Wim Janssens; Willeke F Daamen; Paul Hagedoorn; Hugo Ajm de Wit; Jef Serré; Ghislaine Gayan-Ramirez; Frits Me Franssen; Niki L Reynaert; Jan H von der Thüsen; Henderik W Frijlink
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.